Clinical Trial Update: Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis [Phase 3]

View source ↗

Summary

An open-label Phase 3 study evaluating the effect, safety and tolerability of Betaferon 250 µg in Chinese-origin patients with multiple sclerosis; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2010-02-10